The BIM-IOL system showed a 42% reduction in mean IOP and improved visual acuity, with no serious adverse events linked to ...

WATERLOO, Ontario, April 18, 2023—Scientists from the Centre for Ocular Research & Education (CORE) are poised to unveil multiple advancements in 3D printing next week during the ARVO 2023 Annual ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer long-term medical therapy for chronic ophthalmic conditions, including ...

DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced an agreement with Johns Hopkins University Department of Ophthalmology to ...

Boehringer Ingelheim is continuing to explore its newfound enthusiasm for eye health, penning a $1 billion biobucks pact with Re-Vana Therapeutics. The collaboration will focus on Re-Vana’s ocular ...